Vanguard Investments Australia
UPB

Vanguard Investments Australia’s Upstream Bio Inc UPB Stock Holding History

Vanguard Investments Australia’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3K Hold
4,096
– – ﹤0.01% 2366
2026
Q1 		$36.9K Buy
+4,096
New +$73.7K ﹤0.01% 2373

Other funds holding UPB

Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Investments Australia's UPB Position: Q2 2026 in Review

Vanguard Investments Australia held its Upstream Bio Inc (UPB) position steady in Q2 2026 at 4,096 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2366.

Vanguard Investments Australia first reported a position in UPB in Q1 2026 and has held it in 2 quarters since. The position peaked at $36.9K in Q1 2026. 135 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Vanguard Investments Australia held 4,096 shares of Upstream Bio Inc worth $28.3K as of Q2 2026.
  • Vanguard Investments Australia left its Upstream Bio Inc share count unchanged in Q2 2026.
  • Upstream Bio Inc made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2366 holding.
  • Vanguard Investments Australia first reported a position in Upstream Bio Inc in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Upstream Bio Inc position peaked at $36.9K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.